Jane Street Group, LLC Invitae Corp Call Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$6.28 - $15.59 $222,940 - $553,445	35,500 Added 22.95%	190,200 $1.52 Million
Q4 2021 Feb 15, 2022	BUY	$14.7 - $28.67 $58,800 - $114,680	4,000 Added 2.65%	154,700 $2.36 Million
Q3 2021 Nov 16, 2021	SELL	$24.31 - $33.6 $1.37 Million - $1.9 Million	-56,500 Reduced 27.27%	150,700 $4.28 Million
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $2.74 Million - $4.25 Million	-105,100 Reduced 33.65%	207,200 $6.99 Million
Q1 2021 May 18, 2021	SELL	$33.06 - $56.93 $1.53 Million - $2.64 Million	-46,300 Reduced 12.91%	312,300 $11.9 Million

Q4 2020 Feb 17, 2021	SELL	$39.09 - $57.4 $2.82 Million - $4.14 Million	-72,200 Reduced 16.76%	358,600 $15 Million
Q3 2020 Nov 17, 2020	SELL	$28.43 - $44.67 $4.62 Million - $7.26 Million	-162,600 Reduced 27.4%	430,800 $18.7 Million
Q2 2020 Aug 17, 2020	BUY	$11.71 - $30.29 $6.61 Million - $17.1 Million	564,700 Added 1967.6%	593,400 $18 Million
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $219,268 - $789,250	28,700 New	28,700 $392,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.